news Archives - Page 15 of 100 - Journal for Clinical Studies

Current Edition

Europe

New Survey Finds Fragmented Processes and System Silos Slowing Clinical Trials

Sponsors and CROs accelerate move to modernize and speed study execution There is an industrywide drive to streamline trial processes and systems for better study ...

19 June 2019 Europe | news

Continue Reading →

news

Biotechs dive deeper into targeted cancer research, despite costs

CHICAGO — An AstraZeneca cancer drug works best in people with an uncommon mutation. For a recent study evaluating whether the drug offered benefits to pancreatic...

13 June 2019 news | North America | Regional News

Continue Reading →

Europe

Experimental drug delays Type 1 diabetes in research first

An experimental biologic drug appeared to substantially delay the development of Type 1 diabetes in people at high risk for the chronic condition, surprising results...

13 June 2019 Europe | news | North America | Regional News

Continue Reading →

news

ADA: J&J’s struggling Invokana slashes heart, kidney risks in latest trial win

J&J is awaiting a CKD approval for Invokana after receiving a priority review from the FDA. (Johnson & Johnson) SAN FRANCISCO—Johnson & Johnson and i...

13 June 2019 news | North America | Regional News

Continue Reading →

Europe

Roche touts phase 2 Gazyva data in lupus patients with a potentially fatal kidney complication

Roche cancer drug Gazyva met its endpoint in a phase 2 lupus nephritis study, the company said. (Roche) One brand-new FDA approval and one trial win for its bloo...

13 June 2019 Europe | news | North America | Regional News

Continue Reading →

news

NASH trial miss halves CymaBay’s market value

An experimental drug from CymaBay Therapeutics missed the primary endpoint of a mid-stage NASH trial, cutting the stock price of the California biotech in half Tuesd...

13 June 2019 news | North America | Regional News

Continue Reading →

news

Look here, FDA: Eli Lilly touts Olumiant safety data for unapproved high dose

Eli Lilly is hoping new safety data presented this week will help it make the case with the FDA for a higher dose of rheumatoid arthritis med Olumiant. (Eli Lilly) ...

13 June 2019 news | Regional News

Continue Reading →

news

Phoenix Molecular Designs and WuXi STA Reach Drug Supply Milestone to Support Phase I/Ib Study of PMD-026 for TNBC

VANCOUVER, British Columbia and SAN DIEGO, June 4, 2019 – Phoenix Molecular Designs (PhoenixMD), a privately-held biotechnology company des...

11 June 2019 news | North America | Regional News

Continue Reading →

Asia Pacific

PCI Pharma Services Announces Further Expansion in San Diego to Maintain Industry-Leading Quality, Service and Flexibility

PCI secures third site for Clinical Trials storage, central logistics and distribution center Philadelphia, PA – June 4, 2019 PCI Pharma Services (PCI), a ...

6 June 2019 Asia Pacific | Europe | news | North America | Regional News

Continue Reading →

news

Novartis Kisqali significantly extends life in women with HR+/HER2- advanced breast cancer in MONALEESA-7 trial

Novartis announced statistically significant overall survival (OS) results for Kisqali in combination with endocrine therapy[1]. The Phase 3 MONALEESA-7 trial evalu...

6 June 2019 news | North America | Regional News

Continue Reading →